Physician profile
Nirav Patel
NPI 1710541636
$26,448.49
in general payments reported to CMS, 2019-2025
10 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $333 · 2024: $215 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $1,402 · Travel and Lodging: $1,252 · Consulting Fee: $510 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,137.50 |
| Food and Beverage | $1,401.98 |
| Travel and Lodging | $1,252.49 |
| Consulting Fee | $510.00 |
| Education | $146.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $20,753.64 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $5,248.32 | 2023-2025 | Camzyos |
| Atricure, INC. | $142.34 | 2025 | Synergy Ablation System |
| Idorsia Pharmaceuticals US INC | $120.82 | 2024 | Tryvio |
| Abiomed | $52.71 | 2025 | |
| Merck Sharp & Dohme LLC | $48.57 | 2025 | Capvaxive, Verquvo |
| Pfizer INC. | $26.95 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $24.28 | 2024 | Wainua |
| Amgen INC. | $18.63 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.23 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.